Counting and identifying manufacturers able to supply the U.S. with generic drugs or their base ingredients is critical for promoting the following public health goals: Forecasting national spending on generic drugs; Planning patient treatments when supply
Read More...
Read the complete post at http://healthaffairs.org/blog/2015/10/16/who-makes-this-drug-disclosing-the-identity-of-generic-drug-manufacturers/
Posted
Oct 16 2015, 08:46 AM
by
Health Affairs Blog
Filed under: Public Health, Quality, Featured, Costs and Spending, Drugs and Medical Technology, Health Professionals, FDA, generic drugs, Big Pharma, Waxman-Hatch Act, drug manufacturers